首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Seventy-five percent nephrectomy and the disposition of inorganic mercury in 2,3-dimercaptopropanesulfonic acid-treated rats lacking functional multidrug-resistance protein 2.
【24h】

Seventy-five percent nephrectomy and the disposition of inorganic mercury in 2,3-dimercaptopropanesulfonic acid-treated rats lacking functional multidrug-resistance protein 2.

机译:在缺乏功能性多药耐药蛋白2的2,3-二巯基丙烷磺酸治疗的大鼠中,进行了75%的肾切除术和无机汞的处理2。

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study, we evaluated the disposition of inorganic mercury (Hg(2+)) in sham-operated and 75% nephrectomized (NPX) Wistar and transport-deficient (TR(-)) rats treated with saline or the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA). Based on previous studies, DMSA and TR(-) rats were used as tools to examine the potential role of multidrug-resistance protein 2 (MRP2) in the disposition of Hg(2+) during renal insufficiency. All animals were treated with a low dose (0.5 mumol/kg i.v.) of mercuric chloride (HgCl(2)). At 24 and 28 h after exposure to HgCl(2), matched groups of Wistar and TR(-) rats received normal saline or DMSA (intraperitoneally). Forty-eight hours after exposure to HgCl(2), the disposition of Hg(2+) was examined. A particularly notable effect of 75% nephrectomy in both strains of rats was enhanced renal accumulation of Hg(2+), specifically in the outer stripe of the outer medulla. In addition, hepatic accumulation, fecal excretion, and blood levels of Hg(2+) were enhanced in rats after 75% nephrectomy, especially in the TR(-) rats. Treatment with DMSA increased both the renal tubular elimination and urinary excretion of Hg(2+) in all rats. DMSA did not, however, affect hepatic content of Hg(2+), even in the 75% NPX TR(-) rats. We also show with real-time polymerase chain reaction that after 75% nephrectomy and compensatory renal growth, expression of MRP2 (only in Wistar rats) and organic anion transporter 1 is enhanced in the remaining functional proximal tubules. We conclude that MRP2 plays a significant role in the renal and corporal disposition of Hg(2+) after a 75% reduction of renal mass.
机译:在本研究中,我们评估了经盐水或螯合剂介孔处理的假手术和75%肾切除(NPX)Wistar和运输缺陷型(TR(-))大鼠中无机汞(Hg(2+))的处置-2,3-二巯基琥珀酸(DMSA)。基于以前的研究,DMSA和TR(-)大鼠被用作检查肾功能不全期间多药耐药蛋白2(MRP2)在Hg(2+)处置中的潜在作用的工具。所有动物均接受低剂量(0.5 mumol / kg静脉内)氯化汞(HgCl(2))处理。暴露于HgCl(2)后24和28小时,Wistar和TR(-)大鼠的匹配组接受了生理盐水或DMSA(腹膜内)。暴露于HgCl(2)后48小时,检查了Hg(2+)的处置。在这两种大鼠中,进行75%肾切除术的特别显着效果是增强了Hg(2+)的肾脏积累,特别是在延髓外条纹中。此外,在75%肾切除术后的大鼠,尤其是在TR(-)大鼠中,肝脏的蓄积,粪便排泄和Hg(2+)的血液水平增加。 DMSA治疗可增加所有大鼠的肾小管消除和Hg(2+)的尿排泄。 DMSA不会影响Hg(2+)的肝含量,即使在75%NPX TR(-)大鼠中也是如此。我们还通过实时聚合酶链反应显示,在75%的肾切除术和肾脏代偿性生长后,MRP2(仅在Wistar大鼠中)和有机阴离子转运蛋白1的表达在其余功能性近端小管中得到增强。我们得出的结论是,MRP2在降低肾脏质量75%后在Hg(2+)的肾脏和身体处置中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号